CCM
AMRI

Chicago Capital Management’s Albany Molecular Research Inc AMRI Stock Holding History

Chicago Capital Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-986,958
Closed -$21.4M – 32
2017
Q2 		$21.4M Buy
+986,958
New +$17.9M 4.78% 9

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Chicago Capital Management's AMRI Position: Q3 2017 in Review

Chicago Capital Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 986,958 shares — an estimated $21.4M sold.

Chicago Capital Management first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $21.4M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Chicago Capital Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Chicago Capital Management sold 986,958 Albany Molecular Research Inc shares in Q3 2017, an estimated $21.4M.
  • Chicago Capital Management first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Chicago Capital Management's Albany Molecular Research Inc position peaked at $21.4M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Chicago Capital Management's 13F filing for Q3 2017, filed 11 Oct 2017.